Natasha Cindy Hughes

Natasha Cindy Hughes

Auto-generated profile, based on publicly available information

Natasha Cindy Hughes

Vanderbilt University School of Medicine , Nashville, TN

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2020 in Journal of Religion and Health
Verified
Journal Article
Open access
PDF file
Panagis GaliatsatosPanagis Galiatsatos
Panagis Galiatsatos
KMKimberly Monson
Kimberly Monson
MOMopeninuJesu Oluyinka
MopeninuJesu Oluyinka
DNDanaRose Negro
DanaRose Negro
NHNatasha Hughes
Natasha Hughes
WHW. Daniel Hale
W. Daniel Hale
During the pandemic caused by the severe acute respiratory syndrome coronavirus-2, public health instructions were issued with the hope of curbing the virus’ spread. In an effort to assure accordance with these instructions, equitable strategies for at-risk and vulnerable populations and communities are warranted. One such strategy was our community conference calls, implemented to disseminate information on the pandemic and allow community leaders to discuss struggles and successes. Over the first 6 weeks, we held 12 calls, averaging 125 (standard deviation 41) participants. Participants were primarily from congregations and faith-based organizations that had an established relationship with the hospital, but also included school leaders, elected officials, and representatives of housing associations. Issues discussed included reasons for quarantining, mental health, social isolation, health disparities, and ethical concerns regarding hospital resources. Concerns identified by the community leaders as barriers to effective quarantining and adherence to precautions included food access, housing density, and access to screening and testing. Through the calls, ways to solve such challenges were addressed, with novel strategies and resources reaching the community. This medical–religious resource has proven feasible and valuable during the pandemic and warrants discussions on reproducing it for other communities during this and future infectious disease outbreaks.

21 June 2024 in The Spine Journal
Verified
Journal Article
Closed access
JCJeffrey W. Chen
Jeffrey W. Chen
TZTyler Zeoli
Tyler Zeoli
NHNatasha C. Hughes
Natasha C. Hughes
ALAmanda Lane
Amanda Lane
RBRichard A. Berkman
Richard A. Berkman

12 November 2024 in eLife
Verified
Journal Article
Open access
KOKazuya Ono
Kazuya Ono
AJAmandine Jarysta
Amandine Jarysta
NHNatasha C Hughes
Natasha C Hughes
AJAlma Jukic
Alma Jukic
HCHui Ho Vanessa Chang
Hui Ho Vanessa Chang
BTBasile Tarchini
Basile Tarchini
Otolith organs in the inner ear and neuromasts in the fish lateral-line harbor two populations of hair cells oriented to detect stimuli in opposing directions. The underlying mechanism is highly conserved: the transcription factor EMX2 is regionally expressed in just one hair cell population and acts through the receptor GPR156 to reverse cell orientation relative to the other population. In mouse and zebrafish, loss of Emx2 results in sensory organs that harbor only one hair cell orientation and are not innervated properly. In zebrafish, Emx2 also confers hair cells with reduced mechanosensory properties. Here, we leverage mouse and zebrafish models lacking GPR156 to determine how detecting stimuli of opposing directions serves vestibular function, and whether GPR156 has other roles besides orienting hair cells. We find that otolith organs in Gpr156 mouse mutants have normal zonal organization and normal type I-II hair cell distribution and mechano-electrical transduction properties. In contrast, gpr156 zebrafish mutants lack the smaller mechanically evoked signals that characterize Emx2-positive hair cells. Loss of GPR156 does not affect orientation-selectivity of afferents in mouse utricle or zebrafish neuromasts. Consistent with normal otolith organ anatomy and afferent selectivity, Gpr156 mutant mice do not show overt vestibular dysfunction. Instead, performance on two tests that engage otolith organs is significantly altered – swimming and off-vertical-axis rotation. We conclude that GPR156 relays hair cell orientation and transduction information downstream of EMX2, but not selectivity for direction-specific afferents. These results clarify how molecular mechanisms that confer bi-directionality to sensory organs contribute to function, from single hair cell physiology to animal behavior.

9 June 2025 in Archives of Clinical Neuropsychology
Verified
Journal Article
Open access
ABAnthony E Bishay
Anthony E Bishay
NHNatasha C Hughes
Natasha C Hughes
AAAvi N Albert
Avi N Albert
JDJohn E Dugan
John E Dugan
NONick De Oliveira
Nick De Oliveira
DTDouglas P. Terry
Douglas P. Terry
Objective: While most concussions present with common symptoms, some patients experience atypical manifestations that challenge diagnosis and management. This review synthesizes studies reporting atypical post-concussive symptoms with individual patient-level data, focusing on functional neurologic disorders. Methods: A systematic review was conducted across PubMed, EMBASE, and Cochrane Library databases (01/2000–08/2023). Inclusion criteria were: (1) study participants with concussion or mild traumatic brain injury, (2) trauma and/or sport-related injury, and (3) atypical symptoms without observable imaging findings. Atypical symptoms were defined as neurological symptoms not fully explained by traditional neuroanatomical or neuropathological correlates. Four independent reviewers screened titles, abstracts, and full texts. Data extraction included patient demographics, symptom characteristics, diagnostic methods, treatments, and outcomes. Results: Of the 4725 screened studies, 15 met inclusion criteria (2000–2022). Studies originated from five countries, with 8 (53.3%) from the United States. All studies were case reports (n = 12, 80.0%) or case series (n = 3, 20.0%). The review identified atypical symptoms across five domains: speech disorders (n = 6 studies, primarily new-onset stuttering), psychiatric alterations (n = 4 studies, including dissociative symptoms, Ganser syndrome, and psychotic features), visual changes (n = 1 study), hearing/vestibular disturbances (n = 2 studies), and gait abnormalities (n = 2 studies). Recovery patterns varied widely, ranging from complete resolution within weeks to persistent symptoms over several years. Conclusion: While most patients eventually improved with targeted interventions like speech therapy, psychiatric care, or physical therapy, recovery trajectories varied significantly. Larger prospective studies are needed to determine true incidence rates and establish evidence-based treatment protocols.

18 March 2025 in Brain
Verified
Journal Article
Open access
NHNatasha C Hughes
Natasha C Hughes
HQHelen Qian
Helen Qian
DDDerek J Doss
Derek J Doss
GMGhassan S Makhoul
Ghassan S Makhoul
MZMichael Zargari
Michael Zargari
SBSarah K Bick
Sarah K Bick
Risk-taking behaviour is a symptom of multiple neuropsychiatric disorders and often lacks effective treatments. Reward circuitry regions including the amygdala, orbitofrontal cortex, insula and anterior cingulate have been implicated in risk-taking, but electrophysiological activity predictive of risk taking in these regions is not well understood in humans. Identifying local field potential frequency signatures of risk-taking may provide therapeutic insight into disorders associated with risk-taking. Eleven patients with medically refractory epilepsy who underwent stereotactic electroencephalography with electrodes in the amygdala, orbitofrontal cortex, insula and/or anterior cingulate participated in this experiment. Patients completed a gambling task where they wagered on a visible playing card being higher than a hidden card, betting $5 or $20 on this outcome, while local field potentials were recorded from implanted electrodes. We used linear regression models and cluster-based permutation testing to identify oscillatory power modulations associated with reward prediction error signal. We also computed a risk-taking value for each trial using card number and bet choice and similarly used linear regression and cluster-based permutation testing to identify power changes associated with risk-taking value. We then used two-way ANOVA with bet and risk level to identify power clusters predictive of risky decisions. We used linear mixed effects models to evaluate the relationship between reward prediction error and risky decision signals across trials. Time-frequency clusters associated with reward prediction error were identified in the amygdala (two clusters: all P < 0.001) and orbitofrontal cortex (four clusters: all P < 0.001). Risky decisions were predicted by increased oscillatory power in theta-to-beta frequency range during card presentation in the orbitofrontal cortex (P = 0.00053; η2bet = 0.15, η2risk = 0.27, η2bet*risk = 0.017) and by high beta power in the insula (P = 0.0003; η2bet = 0.15, η2risk = 0.20, η2bet*risk = 0.0018). Subsequent analysis localized these signals to lateral orbitofrontal cortex and posterior insula respectively. The power within an insula cluster associated with risky decisions was associated with a theta-alpha reward prediction error signal in the orbitofrontal cortex (P = 0.023). In addition, an amygdala reward prediction error signal was associated with overall percentage of high bets (P = 0.0015) and a lateral orbitofrontal cortex risky decision signal was associated with high bets in risky scenarios (P = 0.028). Our findings identify and help characterize reward circuitry activity predictive of risk-taking in humans. These findings identify oscillatory power signatures within these regions preceding risky decisions, which may serve as potential biomarkers to inform the development of novel treatment strategies such as closed loop neuromodulation for disorders of risk taking.

11 April 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
NHNatasha C. Hughes
Natasha C. Hughes
HQHelen Qian
Helen Qian
MZMichael Zargari
Michael Zargari
ZZZixiang Zhao
Zixiang Zhao
BSBalbir Singh
Balbir Singh
SBSarah K. Bick
Sarah K. Bick
Risk taking behavior is a symptom of multiple neuropsychiatric disorders and often lacks effective treatments. Reward circuitry regions including the amygdala, orbitofrontal cortex, insula, and anterior cingulate have been implicated in risk-taking by neuroimaging studies. Electrophysiological activity associated with risk taking in these regions is not well understood in humans. Further characterizing the neural signalling that underlies risk-taking may provide therapeutic insight into disorders associated with risk-taking. Eleven patients with pharmacoresistant epilepsy who underwent stereotactic electroencephalography with electrodes in the amygdala, orbitofrontal cortex, insula, and/or anterior cingulate participated. Patients participated in a gambling task where they wagered on a visible playing card being higher than a hidden card, betting $5 or $20 on this outcome, while local field potentials were recorded from implanted electrodes. We used cluster-based permutation testing to identify reward prediction error signals by comparing oscillatory power following unexpected and expected rewards. We also used cluster-based permutation testing to compare power preceding high and low bets in high-risk (<50% chance of winning) trials and two-way ANOVA with bet and risk level to identify signals associated with risky, risk averse, and optimized decisions. We used linear mixed effects models to evaluate the relationship between reward prediction error and risky decision signals across trials, and a linear regression model for associations between risky decision signal power and Barratt Impulsiveness Scale scores for each patient. Reward prediction error signals were identified in the amygdala (p=0.0066), anterior cingulate (p=0.0092), and orbitofrontal cortex (p=6.0E-4, p=4.0E-4). Risky decisions were predicted by increased oscillatory power in high-gamma frequency range during card presentation in the orbitofrontal cortex (p=0.0022), and by increased power following bet cue presentation across the theta-to-beta range in the orbitofrontal cortex ( p =0.0022), high-gamma in the anterior cingulate ( p =0.0004), and high-gamma in the insula ( p =0.0014). Risk averse decisions were predicted by decreased orbitofrontal cortex gamma power ( p =2.0E-4). Optimized decisions that maximized earnings were preceded by decreases within the theta to beta range in orbitofrontal cortex ( p =2.0E-4), broad frequencies in amygdala ( p =2.0E-4), and theta to low-gamma in insula ( p =4.0E-4). Insula risky decision power was associated with orbitofrontal cortex high-gamma reward prediction error signal ( p =0.0048) and with patient impulsivity ( p =0.00478). Our findings identify and help characterize reward circuitry activity predictive of risk-taking in humans. These findings may serve as potential biomarkers to inform the development of novel treatment strategies such as closed loop neuromodulation for disorders of risk taking.